Edition:
United Kingdom

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

3.97USD
25 Apr 2018
Change (% chg)

-- (--)
Prev Close
$3.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
240,696
52-wk High
$7.34
52-wk Low
$0.88

Select another date:

Wed, Mar 7 2018

BRIEF-Viking Therapeutics Q4 Loss Per Share $0.14

* VIKING THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Viking Therapeutics - Pricing Public Offering Of 11 Mln Shares At $5 Per Share

* VIKING THERAPEUTICS ANNOUNCES PRICING OF $55.0 MILLION PUBLIC OFFERING OF COMMON STOCK

BRIEF-Viking Therapeutics Announces Proposed Public Offering Of Common Stock

* VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Sphera Funds Management Ltd Reports 7.43 Pct Passive Stake In Viking Therapeutics

* SPHERA FUNDS MANAGEMENT LTD REPORTS 7.43 PERCENT PASSIVE STAKE IN VIKING THERAPEUTICS INC AS OF DECEMBER 7 - SEC FILING Source text : http://bit.ly/2kdgndu Further company coverage:

BRIEF-Viking Therapeutics Announces Proposed Public Offering Of Common Stock

* VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Viking Therapeutics Announces Positive Top-Line Results From Phase 2 Study Of VK5211 In Patients Recovering From Hip Fracture

* VIKING THERAPEUTICS ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 2 STUDY OF VK5211 IN PATIENTS RECOVERING FROM HIP FRACTURE

BRIEF-Viking Therapeutics reports third quarter 2017 financial results

* Viking Therapeutics reports third quarter 2017 financial results and provides corporate update

Select another date: